Biotech Investment & Portfolio Intelligence

An early biotech investment screen can organise scientific evidence, development milestones, rights questions and commercial assumptions for diligence.

Biotech investment and portfolio intelligence

Record the evidence behind each conclusion and identify the fact that would change the investment view. Use that record to compare assets with different levels of maturity and to focus specialist review.

Explore HERMS solutions

Discuss your requirements with HERMS